Updated Jul 16, 2026
Radhakrishnan Srikanth has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $37K.
Radhakrishnan Srikanth is associated with Pulmonx Corp, a company focused on innovative solutions for lung disease treatment. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 6.0K | $1.54 | $9K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 3.7K | $1.54 | $6K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 2.2K | $1.54 | $3K |
| 2026-06-03 | LUNG | Pulmonx Corp | S — Open-market sale | 2.7K | $1.54 | $4K |
| 2026-03-05 | LUNG | Pulmonx Corp | A — Grant or award | 175.0K | $0.00 | |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 4.2K | $1.43 | $6K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 2.5K | $1.43 | $4K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 3.1K | $1.43 | $4K |
| 2026-03-05 | LUNG | Pulmonx Corp | S — Open-market sale | 756 | $1.43 | $1K |
Radhakrishnan Srikanth is associated with Pulmonx Corp, a company focused on innovative solutions for lung disease treatment. Specific details about his role and contributions to the company are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($37K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Radhakrishnan Srikanth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.